UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$922M |
| 3 |
Amazon
AMZN
|
+$646M |
| 4 |
Tesla
TSLA
|
+$554M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$496M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.04B |
| 2 |
Linde
LIN
|
+$949M |
| 3 |
ExxonMobil
XOM
|
+$313M |
| 4 |
VMW
VMware, Inc
VMW
|
+$217M |
| 5 |
NVIDIA
NVDA
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 13.37% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Klaviyo
KVYO
$5.34B
| $1.21M | ﹤0.01% |
+35,000
| New | +$1.2M |
|
1802
Kratos Defense & Security Solutions
KTOS
$8.74B
| $1.2M | ﹤0.01% |
80,199
+9,969
| +14% | +$148K |
|
1803
Alpha and Omega Semiconductor
AOSL
$950M
| $1.2M | ﹤0.01% |
40,245
+11,334
| +39% | +$352K |
|
1804
Peoples Bancorp
PEBO
$1.5B
| $1.2M | ﹤0.01% |
47,129
| – | – |
|
1805
Healthcare Services Group
HCSG
$1.6B
| $1.19M | ﹤0.01% |
114,506
+33,295
| +41% | +$414K |
|
1806
Driven Brands
DRVN
$2.35B
| $1.19M | ﹤0.01% |
94,855
+12,532
| +15% | +$229K |
|
1807
Palomar
PLMR
$3.55B
| $1.19M | ﹤0.01% |
23,529
| – | – |
|
1808
Westamerica Bancorp
WABC
$1.38B
| $1.19M | ﹤0.01% |
27,514
+2,025
| +8% | +$90.5K |
|
1809
Protagonist Therapeutics
PTGX
$8.79B
| $1.19M | ﹤0.01% |
71,059
+6,281
| +10% | +$122K |
|
1810
Marathon Digital Holdings
MARA
$4.32B
| $1.18M | ﹤0.01% |
139,043
+28,485
| +26% | +$382K |
|
|
CIM
1811
Chimera Investment
CIM
$1.04B
| $1.18M | ﹤0.01% |
72,036
+142
| +0.2% | +$2.49K |
|
1812
Trupanion
TRUP
$1.07B
| $1.18M | ﹤0.01% |
41,828
+2,920
| +8% | +$83K |
|
1813
First Busey Corp
BUSE
$2.57B
| $1.18M | ﹤0.01% |
61,333
| – | – |
|
1814
UFP Technologies
UFPT
$1.97B
| $1.18M | ﹤0.01% |
7,300
+2,000
| +38% | +$350K |
|
1815
Addus HomeCare
ADUS
$2.16B
| $1.18M | ﹤0.01% |
13,831
-3,669
| -21% | -$327K |
|
1816
Agios Pharmaceuticals
AGIO
$1.79B
| $1.17M | ﹤0.01% |
47,461
-203,073
| -81% | -$5.37M |
|
1817
Establishment Labs
ESTA
$2.72B
| $1.17M | ﹤0.01% |
23,881
+1,637
| +7% | +$97.9K |
|
|
PENG
1818
Penguin Solutions Inc
PENG
$2.7B
| $1.17M | ﹤0.01% |
47,942
-439
| -0.9% | -$11.1K |
|
|
AVNS
1819
DELISTED
Avanos Medical
AVNS
| $1.17M | ﹤0.01% |
57,669
-97
| -0.2% | -$2.2K |
|
1820
Rocket Lab Corp
RKLB
$40.6B
| $1.16M | ﹤0.01% |
265,701
+128,929
| +94% | +$784K |
|
1821
Columbus McKinnon
CMCO
$553M
| $1.16M | ﹤0.01% |
33,321
+3,775
| +13% | +$144K |
|
1822
Marten Transport
MRTN
$1.21B
| $1.16M | ﹤0.01% |
58,947
-1,448
| -2% | -$30.6K |
|
1823
Krispy Kreme
DNUT
$548M
| $1.16M | ﹤0.01% |
93,008
+2,258
| +2% | +$31.5K |
|
1824
Kornit Digital
KRNT
$705M
| $1.16M | ﹤0.01% |
61,095
| – | – |
|
1825
Aurinia Pharmaceuticals
AUPH
$1.91B
| $1.15M | ﹤0.01% |
147,701
-955
| -0.6% | -$9.34K |
|
Similar funds
UBS AM's Q3 2023 Portfolio in Review
As of Q3 2023, UBS AM held 2,762 positions worth $223B, up 8.1% from $206B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM deployed $7.28B of net new capital in Q3 2023, opening 89 new positions and adding to 1,400 existing holdings. Its largest new stake was Kenvue: 8,680,819 shares worth $174M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Abbott, an estimated $1.04B trimmed.
- UBS AM's largest Q3 2023 buy was Kenvue: 8,680,819 shares worth $174M.
- UBS AM added most to Apple in Q3 2023, an estimated $1.01B increase.
- UBS AM's biggest Q3 2023 reduction was Abbott, cutting an estimated $1.04B.
- UBS AM fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $128M.
- UBS AM's ten largest holdings make up 26% of its $223B portfolio in Q3 2023.
- UBS AM opened 89 new positions and closed 174 in Q3 2023.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $223B.
Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.